Federal Register / Vol. 75, No. 207 / Wednesday, October 27, 2010 / Notices 66113 

biospecimens will be distributed 

blinded, that is, with an identifier that 

will only be linked to the study 

identification number upon completion 

of laboratory analyses, unless 

arrangements have been made for 

interim analyses beforehand. 

Progress Reports: Brief progress 

reports must be submitted annually to 

judge progress. 

Disposition of Results and Samples: 

No samples provided can be used for 

any purpose other than those 

specifically requested in the proposal 

and approved by the Technical Panel. 

No sample can be shared with others, 

including other investigators, unless 

specified in the proposal and so 

approved. Any unused samples must be 

either discarded or returned to the 

Division Repository, according to the 

wishes of the BRADSC upon completion 

of the approved project. 

Proposed Cost Schedule for Providing 

CPP Specimens: A nominal processing 

fee of approximately $8.00–$16.00 per 

sample, plus express shipping costs is 

anticipated for each sample requested 

and received. Costs will be fully 

estimated at the time of proposal 

acceptance and will take into 

consideration time and materials for the 

collection, storage and processing of the 

specimens by the Division Repository 

along with the preparation of the 

accompanying data files. The material 

costs are for the recurring laboratory 

costs to dispense and prepare the 

samples during collection and the 

computer software needed for the 

preparation of the data files. Because 

size of the shipments and distance to 

laboratories may vary, shipping costs 

will be estimated at the time of proposal 

acceptance. Cost reimbursement 

structures negotiated and accepted as 

part of a final proposal acceptance will 

be honored for one year from the date 

of proposal acceptance. 

Proposed Cost for Accessing CPP 

Microfiche Archives: There is no direct 

cost for accessing the CPP microfiche 

archives, although arrangements will 

have to be made for access to the 

building and is dependent upon the 

space available to accommodate a 

researcher. 

As additional specimens and 

resources from Division projects are 

made available for public use, 

announcements will be made on the 

Division Web site without further 

announcement in the Federal Register. 

As a reminder, the BRADSC and 

Division reserve the right to amend the 

proposal guidelines and cost schedule 

as needed and in keeping with the 

nature and complexity of the applicants’ 

request. 

Dated: October 20, 2010. 

Germaine M. Buck Louis, 

Director and Senior Investigator, Division of 

Epidemiology, Statistics, and Prevention 

Research, Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development. 

[FR Doc. 2010–27183 Filed 10–26–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

NRSA Institutional Research Training (T32). 

Date: November 17, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Melrose Hotel, 2430 Pennsylvania 

Ave., NW., Washington, DC 20037. 

Contact Person: Aileen Schulte, PhD, 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd, Room 6140, MSC 9608, 

Bethesda, MD 20892–9608, 301–443–1225, 

aschulte@mail.nih.gov. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

Novel NeuroAIDS Therapeutics. 

Date: November 22, 2010. 

Time: 12 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852, (Telephone 

Conference Call). 

Contact Person: David W Miller, PhD, 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd., Room 6140, MSC 9608, 

Bethesda, MD 20892–9608, 301–443–9734, 

millerda@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.242, Mental Health Research 

Grants; 93.281, Scientist Development 

Award, Scientist Development Award for 

Clinicians, and Research Scientist Award; 

93.282, Mental Health National Research 

Service Awards for Research Training, 

National Institutes of Health, HHS) 

Dated: October 20, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–27186 Filed 10–26–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Small 

Business: Skeletal Muscle and Exercise 

Physiology. 

Date: November 10–11, 2010. 

Time: 9 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting) 

Contact Person: Richard Ingraham, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4116, 

MSC 7814, Bethesda, MD 20892, 301–496– 

8551, ingrahamrh@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, RFA Panel: 

Developmental Pharmacology. 

Date: December 6–7, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting) 

Contact Person: Janet M Larkin, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 


srobinson on DSKHWCL6B1PROD with NOTICES